Ignite Creation Date:
2024-05-05 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00424606
Status:
COMPLETED
Last Update Posted:
2015-05-20
First Post:
2007-01-18
Brief Title:
Epirubicin and Docetaxel Combination ET or Epirubicin Followed by Docetaxel ET for Node Negative N0 High Risk Breast Cancer Patients
Sponsor:
Hellenic Oncology Research Group
Organization:
Hellenic Oncology Research Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-06
Start Date Type:
None
Primary Completion Date:
2013-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-08
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-18
First Submit QC Date:
January 18 2007
Study First Post Date:
2007-01-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-05-19
Last Update Post Date:
2015-05-20
Last Update Post Date Type:
ESTIMATED